Furthermore, with RBP2 overexpression, the level of RBP2 was lower in CML-BP than CML-CP cells (Figure 3B), which suggests that RBP2 expression was decreased during CML progression. Here, RBP2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.